Idexx Laboratories (IDXX) cash: $180M
Idexx Laboratories held $180M in cash and cash equivalents on Dec 31, 2025, down 37.5% from $288M a year earlier.
From Idexx Laboratories's filings with the SEC · Read the filing · IDXX stock page
Idexx Laboratories cash by year
#1,612 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $180M | -38% |
| Dec 31, 2024 | $288M | -36% |
| Dec 31, 2023 | $454M | +303% |
| Dec 31, 2022 | $113M | -22% |
| Dec 31, 2021 | $144M | – |
Cash of similar companies
Companies in the same industry as Idexx Laboratories, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Lantheus Holdings | $359M | Dec 31, 2025 |
| Idexx Laboratories | $180M | Dec 31, 2025 |
| QuidelOrtho | $170M | Dec 28, 2025 |
| Intellia Therapeutics | $155M | Dec 31, 2025 |
| Neogen | $145M | Nov 30, 2025 |
| Celldex Therapeutics | $28.9M | Dec 31, 2025 |
| Achieve Life Sciences | $20.9M | Dec 31, 2025 |
Questions and answers
What is Idexx Laboratories's cash?
Idexx Laboratories held $180M in cash and cash equivalents on Dec 31, 2025, down 37.5% from $288M a year earlier.
Numbers as reported in Idexx Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology